SlideShare a Scribd company logo
1 of 12
(Department of Applied Pharmaceuticals)
Indian Biosciences and Research Institute
IBRI NOIDA
 India is now among the top five pharmaceutical
emerging markets.
 The Indian Pharma industry has been growing at a
compounded annual growth rate (CAGR) of more
than 15% over the last five years and has significant
growth opportunities.
 The Ministry of Commerce has targeted Indian Pharma
sector exports at US$ 25 billion by 2014 at an annual
growth rate of 25 per cent.
IBRI NOIDA
 FDI, up to 100 per cent, under the automatic route,
would continue to be permitted for Greenfield
investments in the Pharmaceuticals sector.
 In order to encourage production of drugs by
indigenous industries, the 12th Five Year Plan (2012-17)
has recommended capacity building of private sector to
meet WHO-GMP standards and other international
manufacturing standards.
IBRI NOIDA
 A regular student of Pharmacy B.Pharma, M.Pharma.
 A working professional in Pharmaceutical Industry.
 Research scholars' in the same domain.
IBRI NOIDA
 12 months comprehensive course in distance mode
learning pattern.
 6 months advanced course in distance mode learning
only for working professionals.
 3 months certificate course for beginners.
IBRI NOIDA
 Most updated course material
 Course material prepared by highly experienced
professional from the globe.
 Effective learning process.
 Excellent student support for best service.
 Industry Recognized Course.
 Coast effective.
IBRI NOIDA
 Course contains 7 Papers as
 Paper-I: Introduction to Regulatory Affairs and Profession
 Paper-II: International Licensing and Drug Regulatory Affairs
 Paper-III: Regulatory Documentation for Biologics /Medical
Diagnostics and Pharmaceutics (Submission of DMF, Dossiers etc.)
 Paper-IV: Global Regulatory Compliance Systems
 Paper-V: Regulations for Clinical Trials, GMP, GLP and ICH
Guidelines
 Paper-VI: Regulatory Strategy and Quality Assurance Systems
 Paper-VII: Future of Biopharmaceuticals
IBRI NOIDA
 Download Registration Form
 Fill it completely
 Attach your 10th and graduation mark sheet
photocopies self attested.
 Course fee can be paid by Demand Draft / At par
Cheque.
 DD or At par Cheque must be in favor of “Indian
Biosciences and Research Institute”.
 Attach all with registration form and send it to institute
address
IBRI NOIDA
 Complete Study Material will be dispatched to your
mailing address.
 Bimonthly assignments for self assessment.
 Contact classes on the demand to clear doubts.
 Weekly conversation with faculty members.
 Examination and assessment.
 Successful candidates will received Certificate and
mark sheet.
IBRI NOIDA
 Regulatory Affairs is a comparatively new profession which has
developed from the desire of Governments to protect public
health, by controlling the safety and efficacy of products in areas
including pharmaceuticals, veterinary medicines, medical
devices, pesticides, agrochemicals, cosmetics and
complementary medicines.
 The Regulatory Affairs professional’s job is to keep track of the
ever-changing legislation in all the regions in which the
company wishes to distribute its products. With the aim of
providing training IBRI has launched the course in Regulatory
affairs with the mission to train students and professionals who
can help the industry to work under regulatory environment.
IBRI NOIDA
 TO KNOW MORE Click Here !
 Indian Biosciences and Research Institute
C 50, Sector 2, NOIDA 201301
IBRI NOIDA
Indian Biosciences and Research Institute
C 50, Sector 2, NOIDA 201301
www.ibri.org.in, info@ibri.org.in
Phone: 0120-4122315
Mob: 9999509892
IBRI NOIDA

More Related Content

What's hot

REGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIESREGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIESVikas Rathee
 
Regulatory affairs in Pharmaceutical Industry
Regulatory affairs in Pharmaceutical IndustryRegulatory affairs in Pharmaceutical Industry
Regulatory affairs in Pharmaceutical IndustryRama Shukla
 
Introduction to Pharma regulatory affairs
Introduction to Pharma regulatory affairsIntroduction to Pharma regulatory affairs
Introduction to Pharma regulatory affairsGIBT India
 
Best Practices - Injectable Packaging Lines
Best Practices - Injectable Packaging LinesBest Practices - Injectable Packaging Lines
Best Practices - Injectable Packaging LinesManish Bhatkar
 
Drug Regulatory Affairs- 2
Drug Regulatory Affairs- 2Drug Regulatory Affairs- 2
Drug Regulatory Affairs- 2Tanuja Bisht
 
Food Safety Modernization Act (FSMA) regulatory requirements by FDA
Food Safety Modernization Act (FSMA) regulatory requirements by FDAFood Safety Modernization Act (FSMA) regulatory requirements by FDA
Food Safety Modernization Act (FSMA) regulatory requirements by FDABrian Thomas
 
To compare GMP requirement of India, US and Europe for tablets.
To compare GMP requirement of India, US and Europe for tablets.To compare GMP requirement of India, US and Europe for tablets.
To compare GMP requirement of India, US and Europe for tablets.Aakashdeep Raval
 
Basic concepts about regulatory affairs
Basic concepts about regulatory affairsBasic concepts about regulatory affairs
Basic concepts about regulatory affairsRajkumar Koley
 
Need Of Regulatory Affairs In Biotechnology
Need Of Regulatory Affairs In BiotechnologyNeed Of Regulatory Affairs In Biotechnology
Need Of Regulatory Affairs In BiotechnologyShabeenaZaidi
 
TGA Presentation: Biologicals framework updates
TGA Presentation: Biologicals framework updatesTGA Presentation: Biologicals framework updates
TGA Presentation: Biologicals framework updatesTGA Australia
 
Eu and usa key differences 1
Eu and usa key differences 1Eu and usa key differences 1
Eu and usa key differences 1Ann McGee
 
Presentation: Manufacturing medical devices
Presentation: Manufacturing medical devicesPresentation: Manufacturing medical devices
Presentation: Manufacturing medical devicesTGA Australia
 
TGA Presentation: GMP Clearance Information Session,5-7 September 2017
TGA Presentation: GMP Clearance Information Session,5-7 September 2017TGA Presentation: GMP Clearance Information Session,5-7 September 2017
TGA Presentation: GMP Clearance Information Session,5-7 September 2017TGA Australia
 

What's hot (20)

REGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIESREGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
 
Regulatory affairs in Pharmaceutical Industry
Regulatory affairs in Pharmaceutical IndustryRegulatory affairs in Pharmaceutical Industry
Regulatory affairs in Pharmaceutical Industry
 
Regulatory affairs
Regulatory affairsRegulatory affairs
Regulatory affairs
 
Regulatory Practices in India
Regulatory Practices in IndiaRegulatory Practices in India
Regulatory Practices in India
 
Introduction to Pharma regulatory affairs
Introduction to Pharma regulatory affairsIntroduction to Pharma regulatory affairs
Introduction to Pharma regulatory affairs
 
Best Practices - Injectable Packaging Lines
Best Practices - Injectable Packaging LinesBest Practices - Injectable Packaging Lines
Best Practices - Injectable Packaging Lines
 
Drug Regulatory Affairs- 2
Drug Regulatory Affairs- 2Drug Regulatory Affairs- 2
Drug Regulatory Affairs- 2
 
Training in cGMP Environment for Begninners
Training in cGMP Environment for BegninnersTraining in cGMP Environment for Begninners
Training in cGMP Environment for Begninners
 
Food Safety Modernization Act (FSMA) regulatory requirements by FDA
Food Safety Modernization Act (FSMA) regulatory requirements by FDAFood Safety Modernization Act (FSMA) regulatory requirements by FDA
Food Safety Modernization Act (FSMA) regulatory requirements by FDA
 
FDA Regulations
FDA RegulationsFDA Regulations
FDA Regulations
 
Drug Regulatory Affairs (DRA)
Drug Regulatory Affairs (DRA)Drug Regulatory Affairs (DRA)
Drug Regulatory Affairs (DRA)
 
To compare GMP requirement of India, US and Europe for tablets.
To compare GMP requirement of India, US and Europe for tablets.To compare GMP requirement of India, US and Europe for tablets.
To compare GMP requirement of India, US and Europe for tablets.
 
Basic concepts about regulatory affairs
Basic concepts about regulatory affairsBasic concepts about regulatory affairs
Basic concepts about regulatory affairs
 
Session 1 - Mark Paxton, US FDA / APEC Roadmap to Promote Global Medical Prod...
Session 1 - Mark Paxton, US FDA / APEC Roadmap to Promote Global Medical Prod...Session 1 - Mark Paxton, US FDA / APEC Roadmap to Promote Global Medical Prod...
Session 1 - Mark Paxton, US FDA / APEC Roadmap to Promote Global Medical Prod...
 
Product recall overview
Product recall overviewProduct recall overview
Product recall overview
 
Need Of Regulatory Affairs In Biotechnology
Need Of Regulatory Affairs In BiotechnologyNeed Of Regulatory Affairs In Biotechnology
Need Of Regulatory Affairs In Biotechnology
 
TGA Presentation: Biologicals framework updates
TGA Presentation: Biologicals framework updatesTGA Presentation: Biologicals framework updates
TGA Presentation: Biologicals framework updates
 
Eu and usa key differences 1
Eu and usa key differences 1Eu and usa key differences 1
Eu and usa key differences 1
 
Presentation: Manufacturing medical devices
Presentation: Manufacturing medical devicesPresentation: Manufacturing medical devices
Presentation: Manufacturing medical devices
 
TGA Presentation: GMP Clearance Information Session,5-7 September 2017
TGA Presentation: GMP Clearance Information Session,5-7 September 2017TGA Presentation: GMP Clearance Information Session,5-7 September 2017
TGA Presentation: GMP Clearance Information Session,5-7 September 2017
 

Similar to Program Regulatory Affairs by IBRI Noida

Working Capital Management on Cadila Healthcare Limited.
Working Capital Management on Cadila Healthcare Limited.Working Capital Management on Cadila Healthcare Limited.
Working Capital Management on Cadila Healthcare Limited.Moin Panja
 
Opportunities of BDS in Pharmaceutical Industries.pptx
Opportunities of BDS in Pharmaceutical Industries.pptxOpportunities of BDS in Pharmaceutical Industries.pptx
Opportunities of BDS in Pharmaceutical Industries.pptxDr. Manoj Kumbhare
 
Pharma Sector of INDIA
Pharma Sector of INDIAPharma Sector of INDIA
Pharma Sector of INDIAAjay Kumar
 
Body of the project
Body of the projectBody of the project
Body of the projectcordeney
 
Indian Pharma - An Overview by IDMA Secretary General Daara B Patel
Indian Pharma - An Overview by IDMA Secretary General Daara B PatelIndian Pharma - An Overview by IDMA Secretary General Daara B Patel
Indian Pharma - An Overview by IDMA Secretary General Daara B PatelAnup Soans
 
Project on Production and Packaging in Pharmaceutical Industry Emcure By Nikh...
Project on Production and Packaging in Pharmaceutical Industry Emcure By Nikh...Project on Production and Packaging in Pharmaceutical Industry Emcure By Nikh...
Project on Production and Packaging in Pharmaceutical Industry Emcure By Nikh...Nikhil Dhawan
 
Biocon’s nine months revenue continues to deliver steady growth in fy13
Biocon’s nine months revenue continues to deliver steady growth in fy13Biocon’s nine months revenue continues to deliver steady growth in fy13
Biocon’s nine months revenue continues to deliver steady growth in fy13Biocon
 
Working Capital Management
Working Capital ManagementWorking Capital Management
Working Capital ManagementShweta Chandel
 
Pharmacy - Arewarding Carerer (INDIA)
Pharmacy - Arewarding Carerer (INDIA)Pharmacy - Arewarding Carerer (INDIA)
Pharmacy - Arewarding Carerer (INDIA)Bhushan Desai
 
Market Research Report : Clinical trials market in india 2014 - Sample
Market Research Report : Clinical trials market in india 2014 - SampleMarket Research Report : Clinical trials market in india 2014 - Sample
Market Research Report : Clinical trials market in india 2014 - SampleNetscribes, Inc.
 
Syngene IPO feasibility analysis
Syngene IPO feasibility analysisSyngene IPO feasibility analysis
Syngene IPO feasibility analysisBurning Desires
 
FINAL BROCHURE BIOtech JAPAN 2015
FINAL BROCHURE BIOtech JAPAN 2015FINAL BROCHURE BIOtech JAPAN 2015
FINAL BROCHURE BIOtech JAPAN 2015Anil Ram Chauhan
 

Similar to Program Regulatory Affairs by IBRI Noida (20)

Pharmaceutical Sector
Pharmaceutical SectorPharmaceutical Sector
Pharmaceutical Sector
 
Beacon May 2015
Beacon May 2015Beacon May 2015
Beacon May 2015
 
Pharma regulatory affairs
Pharma regulatory affairsPharma regulatory affairs
Pharma regulatory affairs
 
WP-05.pdf
WP-05.pdfWP-05.pdf
WP-05.pdf
 
India
India India
India
 
Working Capital Management on Cadila Healthcare Limited.
Working Capital Management on Cadila Healthcare Limited.Working Capital Management on Cadila Healthcare Limited.
Working Capital Management on Cadila Healthcare Limited.
 
Pharmaceuticals Sector Report September 2017
Pharmaceuticals Sector Report September 2017Pharmaceuticals Sector Report September 2017
Pharmaceuticals Sector Report September 2017
 
Opportunities of BDS in Pharmaceutical Industries.pptx
Opportunities of BDS in Pharmaceutical Industries.pptxOpportunities of BDS in Pharmaceutical Industries.pptx
Opportunities of BDS in Pharmaceutical Industries.pptx
 
Pharma Sector of INDIA
Pharma Sector of INDIAPharma Sector of INDIA
Pharma Sector of INDIA
 
Body of the project
Body of the projectBody of the project
Body of the project
 
Clinical Research Industry- The INDIAN Edge
Clinical Research Industry- The INDIAN EdgeClinical Research Industry- The INDIAN Edge
Clinical Research Industry- The INDIAN Edge
 
Indian Pharma - An Overview by IDMA Secretary General Daara B Patel
Indian Pharma - An Overview by IDMA Secretary General Daara B PatelIndian Pharma - An Overview by IDMA Secretary General Daara B Patel
Indian Pharma - An Overview by IDMA Secretary General Daara B Patel
 
Project on Production and Packaging in Pharmaceutical Industry Emcure By Nikh...
Project on Production and Packaging in Pharmaceutical Industry Emcure By Nikh...Project on Production and Packaging in Pharmaceutical Industry Emcure By Nikh...
Project on Production and Packaging in Pharmaceutical Industry Emcure By Nikh...
 
Biocon’s nine months revenue continues to deliver steady growth in fy13
Biocon’s nine months revenue continues to deliver steady growth in fy13Biocon’s nine months revenue continues to deliver steady growth in fy13
Biocon’s nine months revenue continues to deliver steady growth in fy13
 
Working Capital Management
Working Capital ManagementWorking Capital Management
Working Capital Management
 
Pharmacy - Arewarding Carerer (INDIA)
Pharmacy - Arewarding Carerer (INDIA)Pharmacy - Arewarding Carerer (INDIA)
Pharmacy - Arewarding Carerer (INDIA)
 
blog 3.pdf
blog 3.pdfblog 3.pdf
blog 3.pdf
 
Market Research Report : Clinical trials market in india 2014 - Sample
Market Research Report : Clinical trials market in india 2014 - SampleMarket Research Report : Clinical trials market in india 2014 - Sample
Market Research Report : Clinical trials market in india 2014 - Sample
 
Syngene IPO feasibility analysis
Syngene IPO feasibility analysisSyngene IPO feasibility analysis
Syngene IPO feasibility analysis
 
FINAL BROCHURE BIOtech JAPAN 2015
FINAL BROCHURE BIOtech JAPAN 2015FINAL BROCHURE BIOtech JAPAN 2015
FINAL BROCHURE BIOtech JAPAN 2015
 

Recently uploaded

1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...RKavithamani
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfchloefrazer622
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 

Recently uploaded (20)

1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 

Program Regulatory Affairs by IBRI Noida

  • 1. (Department of Applied Pharmaceuticals) Indian Biosciences and Research Institute IBRI NOIDA
  • 2.  India is now among the top five pharmaceutical emerging markets.  The Indian Pharma industry has been growing at a compounded annual growth rate (CAGR) of more than 15% over the last five years and has significant growth opportunities.  The Ministry of Commerce has targeted Indian Pharma sector exports at US$ 25 billion by 2014 at an annual growth rate of 25 per cent. IBRI NOIDA
  • 3.  FDI, up to 100 per cent, under the automatic route, would continue to be permitted for Greenfield investments in the Pharmaceuticals sector.  In order to encourage production of drugs by indigenous industries, the 12th Five Year Plan (2012-17) has recommended capacity building of private sector to meet WHO-GMP standards and other international manufacturing standards. IBRI NOIDA
  • 4.  A regular student of Pharmacy B.Pharma, M.Pharma.  A working professional in Pharmaceutical Industry.  Research scholars' in the same domain. IBRI NOIDA
  • 5.  12 months comprehensive course in distance mode learning pattern.  6 months advanced course in distance mode learning only for working professionals.  3 months certificate course for beginners. IBRI NOIDA
  • 6.  Most updated course material  Course material prepared by highly experienced professional from the globe.  Effective learning process.  Excellent student support for best service.  Industry Recognized Course.  Coast effective. IBRI NOIDA
  • 7.  Course contains 7 Papers as  Paper-I: Introduction to Regulatory Affairs and Profession  Paper-II: International Licensing and Drug Regulatory Affairs  Paper-III: Regulatory Documentation for Biologics /Medical Diagnostics and Pharmaceutics (Submission of DMF, Dossiers etc.)  Paper-IV: Global Regulatory Compliance Systems  Paper-V: Regulations for Clinical Trials, GMP, GLP and ICH Guidelines  Paper-VI: Regulatory Strategy and Quality Assurance Systems  Paper-VII: Future of Biopharmaceuticals IBRI NOIDA
  • 8.  Download Registration Form  Fill it completely  Attach your 10th and graduation mark sheet photocopies self attested.  Course fee can be paid by Demand Draft / At par Cheque.  DD or At par Cheque must be in favor of “Indian Biosciences and Research Institute”.  Attach all with registration form and send it to institute address IBRI NOIDA
  • 9.  Complete Study Material will be dispatched to your mailing address.  Bimonthly assignments for self assessment.  Contact classes on the demand to clear doubts.  Weekly conversation with faculty members.  Examination and assessment.  Successful candidates will received Certificate and mark sheet. IBRI NOIDA
  • 10.  Regulatory Affairs is a comparatively new profession which has developed from the desire of Governments to protect public health, by controlling the safety and efficacy of products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics and complementary medicines.  The Regulatory Affairs professional’s job is to keep track of the ever-changing legislation in all the regions in which the company wishes to distribute its products. With the aim of providing training IBRI has launched the course in Regulatory affairs with the mission to train students and professionals who can help the industry to work under regulatory environment. IBRI NOIDA
  • 11.  TO KNOW MORE Click Here !  Indian Biosciences and Research Institute C 50, Sector 2, NOIDA 201301 IBRI NOIDA
  • 12. Indian Biosciences and Research Institute C 50, Sector 2, NOIDA 201301 www.ibri.org.in, info@ibri.org.in Phone: 0120-4122315 Mob: 9999509892 IBRI NOIDA